Det åbne langtidsekstensionsstudie omfattede 2562 patienter, der fik tocilizumab 8 mg/ kg med eller uden DMARDs.
The long-term open label extension studies included 2,562 patients who received tocilizumab 8 mg/ kg with or without DMARDs.